Quinoxaline 1,4-di-N-oxide and the Potential for Treating Tuberculosis

Quinoxaline 1,4-di-N-oxide and the Potential for Treating Tuberculosis

New drugs active against drug-resistant tuberculosis are urgently needed to extend the range of TB treatment options to cover drug resistant infections. Quinoxaline derivatives show very interesting biological properties (antibacterial, antiviral, anticancer, antifungal, antihelmintic, insecticidal)...

詳細記述

書誌詳細
主要な著者: Vicente, E. (Esther), Raquel, Pérez-Silanes, S. (Silvia), Aldana, I. (Ignacio), Goldman, R.C. (Robert C.), Monge, A. (Antonio), Solano, B. (Beatriz), Burguete, A. (Asunción), Ancizu, S. (Saioa), Zarranz, B. (Belén), Jaso, A. (Andrés), Marin, A. (Adoración)
フォーマット: info:eu-repo/semantics/article
言語:eng
出版事項: Bentham Science Publishers 2011
主題:
Tuberculosis
Quinoxaline 1,4-di-N-oxide
Mycobacterium
オンライン･アクセス:https://hdl.handle.net/10171/18728

インターネット

https://hdl.handle.net/10171/18728

類似資料